Potential Role of Sesamum Indicum L. Supplementation on Body Mass Index Among Mild to Moderate Hyperlipidemic Patients

Abstract

Hyperlipidemia is the term used to describe abnormally high levels of lipids (fats) in the blood. Cholesterol and triglycerides are the two main types of fat found in blood. Objectives: To investigate the therapeutic potential of Sesamum indicum L. supplementation on BMI among mild to moderate hyperlipidemic patients. Methods: For the four weeks of the trial, 30 mild to moderate hyperlipidemic patients between the ages of 25 and 40 were chosen. The University of Lahore Teaching Hospital in Lahore served as the source of the sample. In a hot air oven, Sesamum indicum L. seeds were roasted for 15 minutes at 200°C. After roasting, seeds were finely powdered using a professional blender. Patients were instructed to follow a 4-week baseline diet regimen and take a daily supplement of 40 mg of Sesamum indicum L. Data on anthropometric measurements, lipid profile biochemical analysis, BMI and nutritional intake were gathered. Results: The mean age of the hyperlipidemic study participants was 32.66 years, with an SD of 4.89 years. The mean weight of study participants before and after therapy were 75.2 ± 1.31 and 73.5 ± 1.10 with a significant difference of 1.7. A striking difference (24%) in the obesity rate between pre and post-treatment was observed. Conclusions: A significant difference in BMI and obesity was observed upon administration of Sesamum indicum seeds in hyperlipidemic patients.